These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22062153)

  • 41. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
    Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative genomic and phylogenetic investigation of the xenobiotic metabolizing arylamine N-acetyltransferase enzyme family.
    Glenn AE; Karagianni EP; Ulndreaj A; Boukouvala S
    FEBS Lett; 2010 Jul; 584(14):3158-64. PubMed ID: 20621844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine.
    Ware JA; Svensson CK
    Biochem Pharmacol; 1996 Nov; 52(10):1613-20. PubMed ID: 8937477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologues.
    Karagianni EP; Kontomina E; Lowe ED; Athanasopoulos K; Papanikolaou G; Garefalaki V; Kotseli V; Zaliou S; Grimaud T; Arvaniti K; Tsatiri MA; Fakis G; Glenn AE; Roversi P; Abuhammad A; Ryan A; Sim RB; Sim E; Boukouvala S
    FEBS J; 2023 May; 290(9):2412-2436. PubMed ID: 36178468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity.
    McQueen CA; Chau B
    Toxicol Sci; 2003 Jun; 73(2):279-86. PubMed ID: 12700401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
    Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insights into the o-acetylation reaction of hydroxylated heterocyclic amines by human arylamine N-acetyltransferases: a computational study.
    Lau EY; Felton JS; Lightstone FC
    Chem Res Toxicol; 2006 Sep; 19(9):1182-90. PubMed ID: 16978022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
    Wagner CR; Bergstrom CP; Koning KR; Hanna PE
    Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insights into how protein dynamics affects arylamine N-acetyltransferase catalysis.
    Zhang N; Walters KJ
    Biochem Biophys Res Commun; 2009 Jul; 385(3):395-401. PubMed ID: 19463782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Catalytic mechanism of hamster arylamine N-acetyltransferase 2.
    Wang H; Liu L; Hanna PE; Wagner CR
    Biochemistry; 2005 Aug; 44(33):11295-306. PubMed ID: 16101314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure of arylamine N-acetyltransferase reveals a catalytic triad.
    Sinclair JC; Sandy J; Delgoda R; Sim E; Noble ME
    Nat Struct Biol; 2000 Jul; 7(7):560-4. PubMed ID: 10876241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacogenetics of NAT: structural aspects.
    Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E
    Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study.
    Dairou J; Atmane N; Rodrigues-Lima F; Dupret JM
    J Biol Chem; 2004 Feb; 279(9):7708-14. PubMed ID: 14672957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
    Walker K; Ginsberg G; Hattis D; Johns DO; Guyton KZ; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):440-72. PubMed ID: 20183529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms and kinetics of human arylamine N-acetyltransferase 1 inhibition by disulfiram.
    Malka F; Dairou J; Ragunathan N; Dupret JM; Rodrigues-Lima F
    FEBS J; 2009 Sep; 276(17):4900-8. PubMed ID: 19664055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) is irreversibly inhibited by inorganic (Hg2+) and organic mercury (CH3Hg+): mechanism and kinetics.
    Ragunathan N; Busi F; Pluvinage B; Sanfins E; Dupret JM; Rodrigues-Lima F; Dairou J
    FEBS Lett; 2010 Aug; 584(15):3366-9. PubMed ID: 20591428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
    Cheon HG; Boteju LW; Hanna PE
    Mol Pharmacol; 1992 Jul; 42(1):82-93. PubMed ID: 1635555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular and Functional Characterization of
    Uno Y; Uehara S; Ijiri M; Kawaguchi H; Asano A; Shiraishi M; Banju K; Murayama N; Yamazaki H
    Drug Metab Dispos; 2022 Nov; 50(11):1429-1433. PubMed ID: 35768074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deficiency of cytosolic arylamine N-acetylation in the domestic cat and wild felids caused by the presence of a single NAT1-like gene.
    Trepanier LA; Cribb AE; Spielberg SP; Ray K
    Pharmacogenetics; 1998 Apr; 8(2):169-79. PubMed ID: 10022754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.